Drug Metabolism and Pharmacokinetics (DMPK) Studies | Charles River

in vitro services 

The In Vitro Services group at Charles River provides information to complement the metabolic, toxicokinetic, and bioanalytical investigations undertaken in pharmaceutical product development. Our in vitro experts provide qualitative and quantitative data to address a variety of regulatory questions. In vitro studies can be conducted with both radiolabelled and non-radiolabelled test articles as required.

Services

  • Species variation in metabolism - hepatic and extrahepatic whole cells (e.g., hepatocytes) and subcellular fractions (e.g., microsomes)
  • Drug-drug interactions (CYP450 inhibition and induction)
  • Drug absorption and kinetics (Caco-2 cells)
  • Influx and efflux transporters
  • Protein binding (equilibrium dialysis or ultrafiltration as well as high-throughput HSA and AGP assay)
  • Ex vivo induction studies using validated CYP-specific assays and Western blotting
  • CYP450 reaction phenotyping
  • Dermal absorption
  • Metabolite stability, profile, and identification
  • hERG channel inhibition (QT prolongation)
  • Aqueous solubility
  • Cell viability (cytotoxicity)
  • Cell proliferation
  • Enzyme assay development


For more information, please contact us at 1.877.CRIVER.1 or askcharlesriver@crl.com.

Discover the full range of Charles River Products and Services
The Source

For more information, contact us at:

1.877.CRIVER.1 (1.877.274.8371)
askcharlesriver@crl.com

view all

News & Events

view all
May 13 - High-Throughput Screening for CNS ...
May 08 - Comparability Studies for Monoclon...
May 28-Jun 01 - Kobe, Japan - Joint Meeting of the International Bone and Mineral Socie...
May 27-May 29 - Almere, The Netherlands - Rodent Surgery Hands-on Training (3-day)

Charles River Laboratories, Inc.